Sophia Ran1, Philip E Thorpe. 1. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390-8594, USA. sophia.ran@utsouthwestern.edu
Abstract
PURPOSE: (1) To determine whether exposure of phosphatidylserine (PS) occurs on vascular endothelium in solid tumors in mice. (2) To determine whether PS exposure can be induced on viable endothelial cells in tissue culture by conditions present in the tumor microenvironment. METHODS AND MATERIALS: Externalized PS in vivo was detected by injecting mice with a monoclonal anti-PS antibody and examining frozen sections of tumors and normal tissues for anti-PS antibody bound to vascular endothelium. Apoptotic cells were identified by anti-active caspase-3 antibody or by TUNEL assay. PS exposure on cultured endothelial cells was determined by 125I-annexin V binding. RESULTS: Anti-PS antibody bound specifically to vascular endothelium in six tumor models. The percentage of PS-positive vessels ranged from 4% to 40% in different tumor types. Vascular endothelium in normal organs was unstained. Very few tumor vessels expressed apoptotic markers. Hypoxia/reoxygenation, acidity, inflammatory cytokines, thrombin, or hydrogen peroxide induced PS exposure on cultured endothelial cells without causing loss of viability. CONCLUSIONS: Vascular endothelial cells in tumors, but not in normal tissues, externalize PS. PS exposure might be induced by tumor-associated oxidative stress and activating cytokines. PS is an abundant and accessible marker of tumor vasculature and could be used for tumor imaging and therapy.
PURPOSE: (1) To determine whether exposure of phosphatidylserine (PS) occurs on vascular endothelium in solid tumors in mice. (2) To determine whether PS exposure can be induced on viable endothelial cells in tissue culture by conditions present in the tumor microenvironment. METHODS AND MATERIALS: Externalized PS in vivo was detected by injecting mice with a monoclonal anti-PS antibody and examining frozen sections of tumors and normal tissues for anti-PS antibody bound to vascular endothelium. Apoptotic cells were identified by anti-active caspase-3 antibody or by TUNEL assay. PS exposure on cultured endothelial cells was determined by 125I-annexin V binding. RESULTS: Anti-PS antibody bound specifically to vascular endothelium in six tumor models. The percentage of PS-positive vessels ranged from 4% to 40% in different tumor types. Vascular endothelium in normal organs was unstained. Very few tumor vessels expressed apoptotic markers. Hypoxia/reoxygenation, acidity, inflammatory cytokines, thrombin, or hydrogen peroxide induced PS exposure on cultured endothelial cells without causing loss of viability. CONCLUSIONS: Vascular endothelial cells in tumors, but not in normal tissues, externalize PS. PS exposure might be induced by tumor-associated oxidative stress and activating cytokines. PS is an abundant and accessible marker of tumor vasculature and could be used for tumor imaging and therapy.
Authors: Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers Journal: Eur J Nucl Med Mol Imaging Date: 2004-05-12 Impact factor: 9.236
Authors: Lisette Ungethüm; Heidi Kenis; Gerry A Nicolaes; Ludovic Autin; Svetla Stoilova-McPhie; Chris P M Reutelingsperger Journal: J Biol Chem Date: 2010-11-15 Impact factor: 5.157
Authors: Olga Vasalatiy; Piyu Zhao; Mark Woods; Andrei Marconescu; Aminta Castillo-Muzquiz; Philip Thorpe; Garry E Kiefer; A Dean Sherry Journal: Bioorg Med Chem Date: 2010-06-18 Impact factor: 3.641
Authors: Daniela Schilling; Mathias Gehrmann; Claudia Steinem; Antonio De Maio; Alan G Pockley; Michael Abend; Michael Molls; Gabriele Multhoff Journal: FASEB J Date: 2009-03-16 Impact factor: 5.191